Summary of HR 4395: Uterine Fibroids Research and Education Bill

Bill Number: HR 4395

Introduced On: July 15, 2025

Current Status: Introduced in House

Referred To: House Committee on Energy and Commerce

Purpose and Intent

HR 4395 aims to enhance research and education regarding uterine fibroids, a common health issue affecting many individuals with uteruses. The bill seeks to address the significant gap in understanding, treatment, and awareness of uterine fibroids, which can lead to various health complications and impact the quality of life for those affected.

Key Provisions

While the specific text of the bill is not provided, the following key provisions are typically expected in legislation of this nature:

• Research Funding: The bill may allocate federal funds to support research initiatives focused on the causes, treatment options, and long-term effects of uterine fibroids.

• Educational Programs: It is likely to establish educational programs aimed at increasing awareness among healthcare providers and the public about uterine fibroids, their symptoms, and available treatments.

• Data Collection: The bill may propose the collection of data on the prevalence and impact of uterine fibroids to inform future research and policy decisions.

• Collaboration with Health Organizations: The bill could encourage partnerships with medical institutions and organizations specializing in women's health to promote comprehensive care and research.

Affected Parties

The primary beneficiaries of HR 4395 would include:

• Individuals with Uterine Fibroids: Those diagnosed with or affected by uterine fibroids would gain access to better information and potentially improved treatment options.

• Healthcare Providers: Medical professionals would receive enhanced training and resources to better understand and treat uterine fibroids.

• Researchers: Increased funding and focus on uterine fibroids would provide researchers with the necessary resources to advance knowledge in this area.

Procedural Aspects

• Committee Review: Following its introduction, HR 4395 has been referred to the House Committee on Energy and Commerce for further discussion and potential amendments.

• Legislative Timeline: As of now, the bill is in the early stages of the legislative process, and its progress will depend on committee actions and subsequent votes in the House.

Conclusion

HR 4395 represents a significant step towards addressing the challenges posed by uterine fibroids through dedicated research and education. By focusing on these areas, the bill aims to improve health outcomes for those affected and enhance the overall understanding of this common condition. As the bill progresses through the legislative process, stakeholders will be watching closely for developments and potential impacts on women's health policy.